Paeds Vivas · genetics-dysmorphology-and-metabolism
Skeletal dysplasias — branching viva
Branching viva on the skeletal dysplasias: recognising the lethal short-limbed newborn and the disproportionate child, classifying by molecular pathway, confirming with a skeletal survey and molecular testing, and matching the therapy to the diagnosis while running surveillance for the lethal complications.
On this page
Study tools
Target exams
Opening branch — the disproportionate child
A two-year-old has rhizomelic shortening, a large head with frontal bossing and midface hypoplasia, trident hands, and genu varum, with normal development. The candidate must give the diagnosis of achondroplasia, name the FGFR3 gain-of-function mechanism that brakes chondrocyte proliferation at the growth plate, and explain why around eighty per cent of cases arise as new variants in average-statured parents. The investigation is a skeletal survey and molecular confirmation of the recurrent FGFR3 variant, and the management is syndrome-specific surveillance plus the consideration of vosoritide. [1] [2]
The examiner probes the surveillance. The candidate names the foramen magnum stenosis and sleep-disordered breathing that threaten the achondroplastic infant, the recurrent otitis media and conductive hearing loss, the risk of hydrocephalus, and the need for syndrome-specific growth charts. The teaching point is that the complications of achondroplasia are life-threatening even when the child looks well, so structured surveillance rather than reassurance is the standard of care. [1] [2]
References4ShowHide
- [1]Pauli RM. Achondroplasia: a comprehensive clinical review. Orphanet J Rare Dis, 2019.PMID 30606190
- [2]Krakow D, Rimoin DL. The skeletal dysplasias. Genet Med, 2010.PMID 20556869
- [3]Forlino A, Marini JC. Osteogenesis imperfecta. Lancet, 2016.PMID 26542481
- [4]Krakow D. Skeletal dysplasias. Clin Perinatol, 2015.PMID 26042906